These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Peritoneovenous shunts for palliation of the patient with malignant ascites. Schumacher DL; Saclarides TJ; Staren ED Ann Surg Oncol; 1994 Sep; 1(5):378-81. PubMed ID: 7531600 [TBL] [Abstract][Full Text] [Related]
25. [Sapheno-peritoneal shunt for the treatment of ascites]. Nagy Z; Gyurkovics E; Kaliszky P; Kupcsulik P Magy Seb; 2001 Aug; 54(4):235-8. PubMed ID: 11550492 [TBL] [Abstract][Full Text] [Related]
26. Peritoneovenous shunting for malignant ascites. Martin GD; Cogbill TH Wis Med J; 1988 Jun; 87(6):31-3. PubMed ID: 2840780 [No Abstract] [Full Text] [Related]
27. Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era. White MA; Agle SC; Padia RK; Zervos EE Am Surg; 2011 Aug; 77(8):1070-5. PubMed ID: 21944526 [TBL] [Abstract][Full Text] [Related]
29. Refractory ascites treated by a peritoneovenous shunt in a patient with congestive heart failure. Jutrin I; Lang R; Ravid M Isr J Med Sci; 1985 Oct; 21(10):853-4. PubMed ID: 4077477 [No Abstract] [Full Text] [Related]
31. [Peritoneovenous shunt in the treatment of persistent ascites in patients with portal hypertension]. Patsiora MD; Lebezev VM Klin Med (Mosk); 1983 May; 61(5):66-8. PubMed ID: 6876704 [No Abstract] [Full Text] [Related]
32. [The continuous peritoneo-jugular shunt (Le Veen's valve) in the treatment of refractory ascites. Personal experience]. Rocca F; Scorti A; Ratti G; D'Errico F; Lualdi M Recenti Prog Med; 1981 Oct; 71(4):420-36. PubMed ID: 7335948 [No Abstract] [Full Text] [Related]
33. [Peritoneo-venous shunt in the treatment of therapy-resistant ascites]. Zühlke HV; Häring R; Semsch B Med Welt; 1981 Apr; 32(15):578-83. PubMed ID: 7231116 [No Abstract] [Full Text] [Related]
34. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation]. Mabrut JY; de la Roche E; Adham M; Ducerf C; Baulieux J Ann Chir; 1998; 52(7):612-7. PubMed ID: 9805798 [TBL] [Abstract][Full Text] [Related]
35. Complications of peritoneovenous shunt for malignant ascites. Lokich J; Reinhold R; Silverman M; Tullis J Cancer Treat Rep; 1980; 64(2-3):305-9. PubMed ID: 6157465 [TBL] [Abstract][Full Text] [Related]
36. [Treatment of patients with portal hypertension complicated by resistant ascites]. Ibadil'din AS; Andreev GN; Tripol'skaia GI; Akhmetova ZhD Vestn Khir Im I I Grek; 1985 Aug; 135(8):32-5. PubMed ID: 4060505 [TBL] [Abstract][Full Text] [Related]
37. Management of malignant ascites with peritoneovenous shunting. Reinhold RB; Lokich JJ; Tomashefski J; Costello P Am J Surg; 1983 Apr; 145(4):455-7. PubMed ID: 6837881 [TBL] [Abstract][Full Text] [Related]
38. [Retransfusion of ascites fluid in cirrhotic patients, using external peritoneovenous and peritoneopulmonary shunts (personal technic)]. Mircea N; Constantinescu C; Jianu E; Constantinescu N Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1984; 33(1):45-54. PubMed ID: 6233645 [No Abstract] [Full Text] [Related]
39. Persistent ascites can be effectively treated by peritoneovenous shunts. Rahman N; De Coppi P; Curry J; Drake D; Spitz L; Pierro A; Kiely E J Pediatr Surg; 2011 Feb; 46(2):315-9. PubMed ID: 21292080 [TBL] [Abstract][Full Text] [Related]